VCYT - VERACYTE, INC.

QQQ $ 617.50 $ 6.52 (1.07 %)

DIA $ 472.45 $ 4.92 (1.05 %)

SPY $ 677.25 $ 5.49 (0.82 %)

TLT $ 91.47 $ 0.04 (0.04 %)

GLD $ 378.59 $ -1.27 (-0.34 %)

Previous Close

$ 36.73

Open

$ 36.25

Bid

$ 34.00 x 200

Ask

$ 37.38 x 10

Day's Range

$ 35.76 - $ 36.85

52 Week Range

$ 22.61 - $ 47.32

Volume

497,580

Average Volume

Market Cap

2.89B

Beta (5Y Monthly)

$ 1.84

PE Ratio (TTM)

$ 109.73

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	02-28-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-05-2023	03-31-2023	10-Q
11	03-01-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-03-2022	06-30-2022	10-Q
14	05-03-2022	03-31-2022	10-Q
15	02-28-2022	12-31-2021	10-K
16	11-09-2021	09-30-2021	10-Q
17	07-29-2021	06-30-2021	10-Q
18	05-10-2021	03-31-2021	10-Q
19	02-22-2021	12-31-2020	10-K
20	11-02-2020	09-30-2020	10-Q
21	07-30-2020	06-30-2020	10-Q
22	05-06-2020	03-31-2020	10-Q
23	02-25-2020	12-31-2019	10-K
24	10-22-2019	09-30-2019	10-Q
25	07-30-2019	06-30-2019	10-Q
26	04-30-2019	03-31-2019	10-Q
27	02-25-2019	12-31-2018	10-K
28	10-29-2018	09-30-2018	10-Q
29	07-23-2018	06-30-2018	10-Q
30	05-01-2018	03-31-2018	10-Q
31	02-27-2018	12-31-2017	10-K
32	11-07-2017	09-30-2017	10-Q
33	07-31-2017	06-30-2017	10-Q
34	05-03-2017	03-31-2017	10-Q
35	03-01-2017	12-31-2016	10-K
36	11-03-2016	09-30-2016	10-Q
37	08-03-2016	06-30-2016	10-Q
38	05-05-2016	03-31-2016	10-Q
39	03-14-2016	12-31-2015	10-K
40	11-05-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Initiates Coverage On Ve...
10/20/2025 10:46:39

Canaccord Genuity analyst Kyle Mikson initiates coverage on Veracyte (NASDAQ:VCYT) with a Hold rating and announces Price Ta...

Freedom Capital Markets Initiates Coverage...
10/17/2025 12:23:32

Freedom Capital Markets analyst Keith Hinton initiates coverage on Veracyte (NASDAQ:VCYT) with a Buy rating and announces Pr...

Reported Sunday, Veracyte Announces BALANC...
09/29/2025 06:34:18

Findings from the first prospective validation trial for biomarker presented at ASTRO 2025

Veracyte To Present First Prospective Data...
09/24/2025 13:08:01

Findings are among nine Decipher-focused abstracts being presented at annual conferenceVeracyte, Inc. (NASDAQ:VCYT), a leading ...

Veracyte Completes Enrollment Of 2,400 Pat...
08/26/2025 12:36:37

Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced it has met its targeted enrollment for the ...

Veracyte Sees FY2025 Sales $496.000M-$504....
08/06/2025 20:29:38

2025 Financial OutlookThe company is raising full-year 2025 testing revenue guidance to $477 million to $483 million, or 14% to...

Veracyte Q2 2025 Adj. EPS $0.44 Beats $0.2...
08/06/2025 20:12:43

Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

cathie-woods-ark-invest-loads-up-on-absci-offloads-crispr-therapeutics

Cathie Wood's Ark Invest Loads Up On Absci...
07/26/2025 05:25:42

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

Veracyte To Replace Triumph Group In The S...
07/24/2025 21:17:39

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250724-1478929/1478929_tgi6.pdf

Veracyte To Present Multiple Afirma GRID S...
07/08/2025 20:09:15

cathie-woods-ark-invest-adds-airbnb-amd-shopify-to-portfolio-slashes-stake-in-circle-internet

Cathie Wood's Ark Invest Adds Airbnb, AMD,...
06/21/2025 04:19:01

cathie-woods-ark-invest-loads-up-on-veracyte-offloads-3d-systems

Cathie Wood's Ark Invest Loads Up On Verac...
06/07/2025 05:24:42

Ark Invest made notable trades on Friday, including purchasing shares of Veracyte Inc. and selling shares of 3D Systems Corp.

Veracyte To Present Eight Abstracts Featur...
05/28/2025 20:13:47

Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that eight abstracts featuring data derived...

UBS Maintains Buy on Veracyte, Lowers Pric...
05/08/2025 18:17:36

UBS analyst Lu Li maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $49 to $42.

Breaking Down Veracyte: 7 Analysts Share T...
05/08/2025 12:01:31

Needham Maintains Buy on Veracyte, Lowers ...
05/08/2025 10:42:47

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $51 to $41.

Veracyte Q1 Adj. EPS $0.31 Beats $0.07 Est...
05/07/2025 20:09:23

Veracyte (NASDAQ:VCYT) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.07 by 342...

Earnings Scheduled For May 7, 2025
05/07/2025 08:33:08

cathie-woods-ark-invest-loads-up-on-intellia-therapeutics-offloads-meta-platforms

Cathie Wood's Ark Invest Loads Up On Intel...
04/26/2025 07:39:55

ARK Invest made significant trades in NTLA, META, VCYT, SYM, BIDU, and PATH. These moves come amidst changes in stock prices. R...